Maryland Senate bill in Session 2026.
Status: introduced. Latest action: April 10, 2026.
Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising.
Providing an addition modification under the corporate income tax for the amount of certain direct-to-consumer advertising expenses for certain covered drugs paid or incurred during the taxable year that are deducted under the Internal Revenue Code; providing for the distribution of revenue attributable to the addition modification; etc.
| Date | Event | Detail |
|---|---|---|
| 2026-02-15 | Introduced | Bill introduced |
| 2026-02-15 | Status | introduced |
| 2026-04-10 | Latest Action | In the Senate - Hearing 3/11 at 1:00 p.m. |